EMBRYO DEVELOPMENT CORP
10KSB40, EX-27, 2000-07-31
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Previous: EMBRYO DEVELOPMENT CORP, 10KSB40, 2000-07-31
Next: SPROTT SECURITIES LTD, SC 13G, 2000-07-31



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL NFORMATION THAT IS EXTRACTED FROM
10-KSB FOR THE YEAR ENDED APRIL 30, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          APR-30-2000
<PERIOD-END>                               APR-30-2000
<CASH>                                           8,894
<SECURITIES>                                         0
<RECEIVABLES>                                    7,628
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                32,574
<PP&E>                                          41,005
<DEPRECIATION>                                  26,905
<TOTAL-ASSETS>                                 667,174
<CURRENT-LIABILITIES>                          270,533
<BONDS>                                        381,500
                                0
                                        600
<COMMON>                                           700
<OTHER-SE>                                      13,841
<TOTAL-LIABILITY-AND-EQUITY>                   667,174
<SALES>                                         43,526
<TOTAL-REVENUES>                                43,526
<CGS>                                           37,610
<TOTAL-COSTS>                                   37,610
<OTHER-EXPENSES>                               132,142
<LOSS-PROVISION>                               167,528
<INTEREST-EXPENSE>                               3,184
<INCOME-PRETAX>                            (1,152,511)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (1,152,511)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (1,152,511)
<EPS-BASIC>                                      (.16)
<EPS-DILUTED>                                    (.16)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission